Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Electro-Chemical Technologies (ECT) was a medical device company primarily known for developing and commercializing the Med-e-Jet needle-free injection system. The technology utilized a high-pressure liquid stream to penetrate the skin, offering a painless alternative to traditional needle-and-syringe delivery for vaccines, insulin, and growth hormones. Based in Miami, Florida, the company targeted both clinical and home-use markets to improve patient compliance and reduce needle-stick injuries. While the Med-e-Jet technology remains a recognized name in needle-free delivery, the original corporate entity is no longer active in its initial form.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Electro-Chemical Technologies.